ABSTRACT
INTRODUCTION

68
Pseudomonas aeruginosa (P. aeruginosa) is a gram-negative pathogen 69 responsible for opportunistic and health-care associated infections such as 70 pneumonia and urinary tract-, surgical site-, and catheter-related blood stream 71 infections (1) . Often, these infections are difficult to treat because of biofilm 72 formation and intrinsic resistance to many antibiotics. In addition, P. aeruginosa 73 easily develops resistance to many currently used antibiotics, and therefore, the 74 development of novel treatment strategies is imperative.
75
Recently, quorum sensing (QS) system has attracted attention as a new 76 therapeutic target (2). P. aeruginosa has two well-characterised QS systems (the Previous studies showed that AHL-negative mutant P. aeruginosa had considerably 85 lower virulence than the wild-type strain (7, 8) . Thus, AHL inhibitor could be a 86 therapeutic agent for infections by gram-negative bacteria.
87
The first AHL-inactivating enzyme, AHL-lactonase AiiA, was isolated from Assay for pyocyanin and elastase production 143 Cell free culture supernatants were obtained by the same method as described 144 above for AHL detection assay. Pyocyanin production was determined using a 145 slightly modified procedure as previously described (17). Four millilitres of the 146 supernatant was mixed with 3 mL of chloroform and centrifuged at 1,700 g for 5 min.
MATERIALS AND METHODS
147
Two millilitres of the lower organic layer containing pyocyanin was collected, and 
Assessment of cytotoxicity
158
The human alveolar epithelial cell line A549 was cultured in RPMI 1640 159 medium with 10% foetal bovine serum, 100 U of penicillin/mL and 100 μg of 160 streptomycin/mL at 37°C with 5% CO 2 . After achieving confluence, the cells were 161 diluted to 2.0 x 10 5 cells/mL and 100 μL aliquots were dispensed in a 96-well plate.
162
After overnight incubation, the cells were washed and infected with P. aeruginosa 
Statistical analyses
225
The data are expressed as mean ± standard error of the mean (SEM).
226
Differences between groups were examined using the unpaired Student's t test or 227 the Mann-Whitney's U test, as appropriate depending on the normality of data 228 distribution. Survival analysis was performed using the log rank test, and the 229 survival rate was calculated by the Kaplan-Meier method. A significant difference 230 was defined as a P value less than or equal to 0.05. 
RESULTS
233
Expression of AiiM in P. aeruginosa reduced AHL accumulation 234 As seen in Fig. 1 , short-and long-chain AHL (C4-HSL, C6-HSL, and showed approximately half the level of cytotoxicity compared with PAO1/pMJT1 at 256 9-15 h post infection (Fig. 3) . with PAO1/pMJT1-aiiM compared to those infected with PAO1/pMJT1 (Fig. 4a) .
263
We further investigated whether AiiM could reduce local infection and systemic inflammation accompanied by haemorrhage into the alveolar spaces ( Fig. 5a and b) .
276
In addition, the reduced levels of haemoglobin, albumin, and LDH in the cell-free 277 BAL fluids of PAO1/pMJT1-aiiM infected mice (Fig. 5c-e) were also observed. The total cell counts and neutrophil percentage in the BAL fluid of both the 282 infected groups increased compared to the uninfected control, with no significant 283 differences between the two groups ( Fig. 6a and b) ; however, MPO activity, aeruginosa PAO1/pMJT1-aiiM was significantly lower than that of the 286 PAO1/pMJT1-infected mice (Fig. 6c) .
287
The levels of pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) in the BAL 288 fluid were also significantly lower in the PAO1/pMJT1-aiiM-infected mice than in the 289 PAO1/pMJT1-infected mice (Fig. 7a-c) . MIP-2 level tended to be lower in the 290 PAO1/pMJT1-aiiM-infected group than in the PAO1/pMJT1-infected group, 291 although the decrease was not statistically significant (Fig. 7d) . Therefore, these This is the first study demonstrating that AiiM could serve as a potent inhibitor of P. 
